Randomized phase II study of CPT-11 versus PTX versus each combination chemotherapy with S-1 for advanced gastric cancer that is refractory to S-1 or S-1 plus CDDP: OGSG0701

被引：0
|
作者：
Tomono Kawase
Hiroshi Imamura
Masahiro Goto
Yutaka Kimura
Shugo Ueda
Jin Matsuyama
Kazuhiro Nishikawa
Naotoshi Sugimoto
Junya Fujita
Takao Tamura
Norimasa Fukushima
Hisato Kawakami
Daisuke Sakai
Yukinori Kurokawa
Toshio Shimokawa
Taroh Satoh
机构：
[1] Toyonaka Municipal Hospital,Department of Surgery
[2] Osaka Medical College Hospital,Cancer Chemotherapy Center
[3] Kinki University,Department of Surgery, Faculty of Medicine
[4] Kitano Hospital,Department of Gastroenterological Surgery
[5] Higashiosaka City Medical Center,Department of Gastroenterological Surgery
[6] Osaka General Medical Center,Department of Surgery
[7] Osaka International Cancer Institute,Department of Medical Oncology
[8] Sakai City Medical Center,Department of Surgery
[9] Kindai University,Department of Medical Oncology, Faculty of Medicine
[10] Yamagata Prefectural Central Hospital,Department of Surgery
[11] Osaka University Graduate School of Medicine,Department of Frontier Science for Cancer and Chemotherapy
[12] Osaka University Graduate School of Medicine,Department of Gastroenterological Surgery
[13] Wakayama Medical University,Clinical Study Support Center
来源：
International Journal of Clinical Oncology | 2021年 / 26卷
关键词：
Gastric cancer; Second-line chemotherapy; Paclitaxel; Irinotecan; S-1;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1871 / 1880
页数：9
相关论文
共 50 条
  • [1] Randomized phase II study of CPT-11 versus PTX versus each combination chemotherapy with S-1 for advanced gastric cancer that is refractory to S-1 or S-1 plus CDDP: OGSG0701
    Kawase, Tomono
    Imamura, Hiroshi
    Goto, Masahiro
    Kimura, Yutaka
    Ueda, Shugo
    Matsuyama, Jin
    Nishikawa, Kazuhiro
    Sugimoto, Naotoshi
    Fujita, Junya
    Tamura, Takao
    Fukushima, Norimasa
    Kawakami, Hisato
    Sakai, Daisuke
    Kurokawa, Yukinori
    Shimokawa, Toshio
    Satoh, Taroh
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2021, 26 (10) : 1871 - 1880
  • [2] Randomized phase II study of CPT-11 versus PTX versus each combination chemotherapy with S-1 in patients with advanced gastric cancer refractory to S-1 or S-1 plus CDDP.
    Kawase, Tomono
    Imamura, Hiroshi
    Gotoh, Masahiro
    Kimura, Yutaka
    Ueda, Shugo
    Matsuyama, Jin
    Nishikawa, Kazuhiro
    Sugimoto, Naotoshi
    Fujita, Junya
    Tamura, Takao
    Fukushima, Norimasa
    Kawabata, Ryohei
    Kurokawa, Yukinori
    Shimokawa, Toshio
    Sakai, Daisuke
    Tsujinaka, Toshimasa
    Furukawa, Hiroshi
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [3] A randomized phase II factorial design trial of CPT-11 versus PTX versus each combination with S-1 in patients with advanced gastric cancer refractory to S-1: Final results of OGSG0701.
    Nishikawa, Kazuhiro
    Imamura, Hiroshi
    Kawase, Tomono
    Gotoh, Masahiro
    Kimura, Yutaka
    Ueda, Shugo
    Matsuyama, Jin
    Kawada, Junji
    Sugimoto, Naotoshi
    Fujita, Junya
    Tamura, Takao
    Fukushima, Norimasa
    Sakai, Daisuke
    Shimokawa, Toshio
    Kurokawa, Yukinori
    Satoh, Taroh
    Tsujinaka, Toshimasa
    Furukawa, Hiroshi
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [4] Randomized phase II study of S-1/CDDP plus TSU-68 versus S-1/CDDP in patients with advanced gastric cancer
    Yamaguchi, Kensei
    Koizumi, Wasaburo
    Hosaka, Hisashi
    Takinishi, Yasutaka
    Nakayama, Norisuke
    Hara, Takuo
    Muro, Kei
    Baba, Hideo
    Sasaki, Yasutsuna
    Nishina, Tomohiro
    Fuse, Nozomu
    Esaki, Taito
    Takagi, Masakazu
    Gotoh, Masahiro
    Kitamura, Ryuichi
    Matsumoto, Hideki
    Sasaki, Tsuneo
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [5] RANDOMIZED PHASE II STUDY OF CPT-11 VS PTX; +/-S1 IN ADVANCED GASTRIC CANCER REFRACTORY TO S1 OR S1+PLATINUM(OGSG0701)
    Sugimoto, Naotoshi
    Imamura, Hiroshi
    Goto, Masahiro
    Kimura, Yutaka
    Ueda, Shugo
    Kurokawa, Yukinori
    Sakai, Daisuke
    Shimokawa, Toshio
    Tsujinaka, Toshimasa
    Furukawa, Hiroshi
    ANNALS OF ONCOLOGY, 2014, 25
  • [6] Comparison of S-1 and cisplatin combination versus S-1 adjuvant chemotherapy for advanced gastric cancer
    Kim, Hyo Song
    Jeung, Hei-Cheul
    Jung, Minkyu
    Kim, Hye Ryun
    Ahn, Ji Yeong
    Kim, Hyoung-Il
    Cheong, Jae-Ho
    Hyung, Woo Jin
    Noh, Sung Hoon
    Chung, Hyun Cheol
    Rha, Sun Young
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [7] Phase II trial of biweekly CPT-11 plus CDDP for patients with unresectable or recurrent gastric cancer refractory to S-1
    Rino, Y.
    Oshima, T.
    Yukawa, N.
    Yamada, R.
    Sato, T.
    Takahashi, M.
    Matsukawa, H.
    Yamamoto, Y.
    Shiraishi, R.
    Masuda, M.
    Imada, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [8] Phase 1 study of CPT-11 plus S-1 for patients with metastatic gastric cancer
    Tsujinaka, T
    Narahara, H
    Takiuchi, H
    Furukawa, H
    Taguchi, T
    INTERNATIONAL JOURNAL OF CANCER, 2002, : 426 - 426
  • [9] Phase I/II study of CPT-11 plus S-1 in patients with advanced gastric cancer.
    Komatsu, Y
    Yuuki, S
    Fuse, N
    Takei, M
    Miyagishima, T
    Kudo, M
    Hashino, S
    Asaka, M
    Sakata, Y
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 361S - 361S
  • [10] RANDOMIZED PHASE II TRIAL OF S-1 PLUS IRINOTECAN VERSUS S-1 PLUS PACLITAXEL AS FIRST-LINE TREATMENT FOR ADVANCED GASTRIC CANCER (OGSG0402)
    Fujitani, K.
    Takiuchi, H.
    Sugimoto, N.
    Imamura, H.
    Iijima, S.
    Imano, M.
    Kimura, Y.
    Kurokawa, Y.
    Tsujinaka, T.
    Furukawa, H.
    ANNALS OF ONCOLOGY, 2010, 21 : 256 - 256
12345